Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidermal Growth Factor Signaling in Transformed Cells
Stephan Lindsey, Sigrid A. Langhans
International review of cell and molecular biology (2014), pp. 1-41
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

RAS/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression
Setareh Rezatabar, Ansar Karimian, Vahid Rameshknia, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 9, pp. 14951-14965
Closed Access | Times Cited: 261
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation
Xiaozheng Chen, Aiqin Gao, Fang Zhang, et al.
Theranostics (2021) Vol. 11, Iss. 7, pp. 3392-3416
Open Access | Times Cited: 112
Novel 1,3,5-triazine-based pyrazole derivatives as potential antitumor agents and EFGR kinase inhibitors: synthesis, cytotoxicity, DNA binding, molecular docking and DFT studies
M.S. Raghu, C.B. Pradeep Kumar, M.K. Prashanth, et al.
New Journal of Chemistry (2021) Vol. 45, Iss. 31, pp. 13909-13924
Closed Access | Times Cited: 105
Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways
Mário Šereš, Katarina Spacayova, Zdena Sulová, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 248-248
Open Access | Times Cited: 2
Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway
Weiwei Sheng, Chuanping Chen, Ming Dong, et al.
Cell Death and Disease (2017) Vol. 8, Iss. 10, pp. e3147-e3147
Open Access | Times Cited: 144
Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation
Donna Collins-McMillen, Jason Buehler, Megan A. Peppenelli, et al.
Viruses (2018) Vol. 10, Iss. 8, pp. 444-444
Open Access | Times Cited: 119
Glucocorticoids, genes and brain function
Grzegorz R. Juszczak, Adrian Stankiewicz
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 82, pp. 136-168
Closed Access | Times Cited: 111
Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication
Jason Buehler, Sebastian Zeltzer, Justin M. Reitsma, et al.
PLoS Pathogens (2016) Vol. 12, Iss. 5, pp. e1005655-e1005655
Open Access | Times Cited: 96
Discovery of a novel series of substituted quinolines acting as anticancer agents and selective EGFR blocker: Molecular docking study
C.B. Pradeep Kumar, M.S. Raghu, B.S. Prathibha, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 44, pp. 128118-128118
Closed Access | Times Cited: 94
Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings
R. Donald Harvey, Val R. Adams, Tyler Beardslee, et al.
Journal of Oncology Pharmacy Practice (2020) Vol. 26, Iss. 6, pp. 1461-1474
Open Access | Times Cited: 86
Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer Metastasis
Busra Buyuk, Sha Jin, Kaiming Ye
Cellular and Molecular Bioengineering (2021) Vol. 15, Iss. 1, pp. 1-13
Open Access | Times Cited: 68
Mechanism of Action of Collagen and Epidermal Growth Factor: A Review on Theory and Research Methods
Mohamad Hesam Shahrajabian, Wenli Sun
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 4, pp. 453-477
Closed Access | Times Cited: 33
New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108297-108297
Closed Access | Times Cited: 1
EGFR Family Members’ Regulation of Autophagy Is at a Crossroads of Cell Survival and Death in Cancer
Elizabeth S. Henson, Yongqiang Chen, Spencer B. Gibson
Cancers (2017) Vol. 9, Iss. 4, pp. 27-27
Open Access | Times Cited: 80
High‐resolution mapping of cancer cell networks using co‐functional interactions
Evan A. Boyle, Jonathan K. Pritchard, William J. Greenleaf
Molecular Systems Biology (2018) Vol. 14, Iss. 12
Open Access | Times Cited: 72
Precision medicine in cholangiocarcinoma
Antonio Pellino, Fotios Loupakis, Massimiliano Cadamuro, et al.
Translational Gastroenterology and Hepatology (2018) Vol. 3, pp. 40-40
Open Access | Times Cited: 70
PEDV and PDCoV Pathogenesis: The Interplay Between Host Innate Immune Responses and Porcine Enteric Coronaviruses
Surapong Koonpaew, Samaporn Teeravechyan, Phanramphoei Namprachan Frantz, et al.
Frontiers in Veterinary Science (2019) Vol. 6
Open Access | Times Cited: 70
Molecular landscape of recurrent cervical cancer
Divya Adiga, Sangavi Eswaran, Deeksha Pandey, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103178-103178
Closed Access | Times Cited: 67
Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency
Jason Buehler, Ethan Carpenter, Sebastian Zeltzer, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 11, pp. e1008037-e1008037
Open Access | Times Cited: 55
Disease relevant modifications of the methylome and transcriptome by particulate matter (PM2.5) from biomass combustion
Katharina Heßelbach, Gwang-Jin Kim, Stephan Flemming, et al.
Epigenetics (2017) Vol. 12, Iss. 9, pp. 779-792
Open Access | Times Cited: 52
Porcine Epidemic Diarrhea Virus-Induced Epidermal Growth Factor Receptor Activation Impairs the Antiviral Activity of Type I Interferon
Lijun Yang, Jiayu Xu, Longjun Guo, et al.
Journal of Virology (2018) Vol. 92, Iss. 8
Open Access | Times Cited: 52
Dysregulation of TTP and HuR plays an important role in cancers
Hao Wang, Nannan Ding, Jian Guo, et al.
Tumor Biology (2016) Vol. 37, Iss. 11, pp. 14451-14461
Closed Access | Times Cited: 48
Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: Design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives
Eman Y. Ahmed, Weam Salah Goda Elserwy, Mohamed F. El‐Mansy, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 48, pp. 128258-128258
Closed Access | Times Cited: 35
The Story of EGFR: From Signaling Pathways to a Potent Anticancer Target
Saloni Ramani, Sayalee Samant, Sonal M. Manohar
Future Medicinal Chemistry (2022) Vol. 14, Iss. 17, pp. 1267-1288
Closed Access | Times Cited: 24
Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies
Charli Dominguez, Kwong-Yok Tsang, Claudia Palena
Cell Death and Disease (2016) Vol. 7, Iss. 9, pp. e2380-e2380
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top